BFM is a leading developer of molecular kits for research and diagnostic application. Through collaborations with private and academic Institutes, we are developing new approaches to improve human health. Currently, we are very active in the field of age-related diseases and food. Our experience ranges from molecular and cellular biology, medicinal chemistry and nanomedicine. With more than 30 years of combined experience, we provide solutions to cutting-edge organizations to speed up their programs.
Founder and CEO
Flavio has over 20 years of experience in molecular and cellular biology. He is an expert in genetics and cancer biology with particular interest in drug discovery and nanomedicine. From 1998 to 2003 he worked at CNR-IGM of Pavia (Italy) on the molecular and genetic analysis of two genes mapped on chromosome X candidate of early menopause. From 2003 to 2008 he worked mainly in the molecular and epigenetics characterization of a genomic region of the X chromosome responsible of early menopause at San Raffaele Hospital (Italy). After this period, Flavio decided to change the field of interest and moved in Philadelphia (US) at Temple University to study the signaling pathway of Retinoblastoma, which govern cell cycle control. After five years, he came back in Italy thanks to an European funded project to start an exciting program in the field of cancer nanomedicine at CRO of Aviano. Currently, he is a researcher at Ca’ Foscari University at the department of Molecular Sciences and Nanosystems and adjunct professor at Temple University. Flavio has authored more than 50 peer reviewed scientific manuscripts and publications. He is co-author of two patents and has been invited to speak at International Conferences. Flavio earned his undergraduate degree from University of Pavia and the PhD from University of Siena (Italy).
Tiziano Tuccinardi is Associate Professor of Medicinal Chemistry at the Department of Pharmacy of the University of Pisa. Since July 2016 he is also Adjunct Associate Professor at the Department of Biology, Temple University’s College of Science and Technology, Philadelphia, PA, USA. In 2010, he was awarded with the ‘Farmindustria Prize for Pharmaceutical Research’, which is a national award dedicated to scientists younger than 40 years old. Since 2009, he has been a member of the Department for the PhD course “Science of Drug and Bioactive Substances”.His research interests include drug and lead discovery, with a focus on computer-assisted approaches and medicinal chemistry, including synthesis of small molecules, virtual and biomolecular screening. He has published more than 180 papers with an H-index of 34 and more than 3400 citations.
Carlotta Granchi graduated in Pharmaceutical Chemistry and Technology (CTF) in 2007 at the University of Pisa (110/110 cum laude). Then, she obtained her PhD in Medicinal Chemistry in 2011 at the University of Pisa. In 2009 she spent a research period as visiting student in the group of Prof. Paul J. Hergenrother at the Department of Chemistry at the University of Illinois at Urbana-Champaign (Urbana, IL, USA). From 2011 to 2016 she was a post-doctoral fellow at the Department of Pharmacy of the University of Pisa, and during this period she took part to the US National Institutes of Health (NIH) research project “Design, synthesis, and evaluation of lactate dehydrogenase inhibitors”. In 2014-2015 she attended a Master course in “Pharmaceutical Management, Marketing and Regulatory Affairs”. Since November 2016 Carlotta is researcher at the Department of Pharmacy, University of Pisa. She published more than 40 papers and 4 patents.